SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

08 October, 2007

 

 

PROTHERICS PLC

(Translation of Registrant’s Name Into English)

 

 

The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F       X              Form 40-F               

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):             

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):             

 

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes                     No          X     

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-              .

 

 

The Registrant is furnishing a copy of its announcements as reported to the Company Announcements Office of the London Stock Exchange.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

       

 

PROTHERICS PLC

       

Date: 08 October, 2007

 

By:

 

/s/ Rolf Soderstorm

       

Rolf Soderstorm

       

Finance Director

Protherics PLC 6 monthly Block Listing Return Unapproved Share Option Scheme London, UK; Brentwood, TN; 8 October 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that, today, the following 6 monthly block listing return in respect of the Company's Unapproved Share Option Scheme has been lodged with the FSA in accordance with Listing Rule 3.5.6. Name of applicant: Protherics PLC Name of scheme: Protherics PLC Unapproved Share Option Scheme Period of return: From: 9 April 2007 To: 8 October 2007 Balance under scheme from previous return: 3,151,947 The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: Nil Number of securities issued/allotted under scheme during period: 25,000 Balance under scheme not yet issued/allotted at end of period: 3,126,947 Number and class of securities originally listed and the date of admission: 4,559,122 Ordinary Shares (date of admission: 8 April 2005) Total number of securities in issue at the end of the period: 339,346,822 Ends For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, David Yates +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Protherics Charts.
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Protherics Charts.